Small Bowel Perforation in Roux-en-Y Gastric Bypass (RYGB) Secondary to Apolipoprotein A-IV (AApoA-IV) Type Amyloidosis - Summary - MDSpire

Small Bowel Perforation in Roux-en-Y Gastric Bypass (RYGB) Secondary to Apolipoprotein A-IV (AApoA-IV) Type Amyloidosis

  • By

  • Mona Zhi Ling Mai Jiang

  • Stefaan De Clercq

  • March 29, 2025

  • 0 min

Share

Objective:

To describe a rare case of AApoA-IV type amyloidosis causing small bowel perforation post-RYGB and examine considerations for bariatric surgery in IBD patients, highlighting its implications for clinical practice.

Key Findings:
  • Small bowel perforation can occur post-RYGB due to AApoA-IV type amyloidosis, necessitating vigilance in IBD patients.
  • Histopathological analysis revealed characteristic changes consistent with amyloidosis, underscoring the importance of thorough post-operative evaluation.
  • The patient had a successful recovery post-revision surgery with minimal symptoms, suggesting favorable outcomes with careful management.
Interpretation:

This case highlights the need for awareness of amyloidosis as a potential complication in bariatric surgery, especially in patients with inflammatory bowel disease, and suggests further research into its mechanisms.

Limitations:
  • The rarity of the case limits generalizability.
  • Long-term outcomes of AApoA-IV amyloidosis in bariatric surgery patients remain unclear, indicating a need for further research.
Conclusion:

Bariatric surgery can be performed safely in IBD patients, but careful consideration of potential complications like amyloidosis is essential.

Original Source(s)

Related Content